TEVA

Teva Pharmaceutical Industries Stock Analysis

AI Rating

Neutral
  • Quality0/10
  • Growth↑ 9/10
  • Value↓ 4/10
Teva Pharmaceutical Industries sales and earnings growth
TEVA Growth
Great
  • Revenue Y/Y↓ 4.32%
  • EPS Y/Y↑ 184.83%
  • FCF Y/Y↑ 53.27%
Teva Pharmaceutical Industries gross and profit margin trends
TEVA Profitability
Neutral
  • Gross margin ↑ 51.80%
  • EPS margin↓ 8.20%
  • ROIC 5Y↓ 1.85%
Teva Pharmaceutical Industries net debt vs free cash flow
TEVA Risk
Fair
  • Debt / Equity↑ 2.2
  • Debt / FCF↑ 11.8
  • Interest coverage↓ 2.3

Teva Pharmaceutical Industries stock is less volatile than the overall market, so it's low risk. We give it a Fair risk rating.

More Drug Manufacturers - Specialty & Generic stocks ↗